Institutional investors purchased a net $1.9 million shares of NVIV during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 23.37% of shares outstanding that institutional investors hold is actually below the Engineering & Construction industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 542.5 Thousand shares of InVivo Therapeutics Holdi...